Metabolic Surgery in Type 2 Diabetes: Roux-en-Y Gastric Bypass or Sleeve Gastrectomy as Procedure of Choice?

被引：0
作者：
Josep Vidal
Amanda Jiménez
Ana de Hollanda
Lílliam Flores
Antonio Lacy
机构：
[1] Hospital Clinic Universitari,Obesity Unit, Endocrinology and Nutrition Department
[2] Institut d’Investigacions Biomèdiques August Pi Sunyer (IDIBAPS),Gastrointestinal Surgery Department
[3] Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM),undefined
[4] Hospital Clinic Universitari,undefined
来源：
Current Atherosclerosis Reports | 2015年 / 17卷
关键词：
Sleeve gastrectomy; Gastric bypass; Duodenal switch; Type 2 diabetes mellitus; Weight loss;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In recent years, a marked increase in the relative use of sleeve gastrectomy (SG) has occurred. However, long-term head-to-head comparison of the impact of this bariatric surgery (BS) procedure with the still considered “gold standard” Roux-en-Y gastric bypass (GBP) in subjects with type 2 diabetes mellitus (T2DM) is surprisingly low. The aim of this review manuscript is to appraise current evidence on the potential of GBP and SG as long-term therapeutic tool for subjects with T2DM. In our opinion, unfortunately, review of current literature does not allow to properly answer which of the two surgeries would be better as procedure of choice for subjects with T2DM. Arguably, the apparent superiority of GBP over SG could be overcome by the addition of a malabsortive component to SG in a staged approach restricted to those failing to achieve the desired metabolic outcomes. Nonetheless, whether this serves as basis for the election of SG as primary strategy for those with T2DM is questionable.
引用
收藏
相关论文
共 225 条
[1]  
Colquitt JL(2014)Surgery for weight loss in adults Cochrane Database Syst Rev 8 CD003641-52
[2]  
Pickett K(2007)Effects of bariatric surgery on mortality in Swedish obese subjects N Engl J Med 357 741-37
[3]  
Loveman E(2004)Bariatric surgery: a systematic review and meta-analysis JAMA 292 1724-13
[4]  
Frampton GK(2014)Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes N Engl J Med 370 2002-85
[5]  
Sjöström L(2012)Bariatric surgery versus conventional medical therapy for type 2 diabetes N Engl J Med 366 1577-31
[6]  
Narbro K(2012)Health benefits of gastric bypass surgery after 6 years JAMA 308 1122-4
[7]  
Sjöström CD(2003)Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient Obes Surg 13 861-80
[8]  
Karason K(2008)Staged laparoscopic sleeve gastrectomy followed by Roux-en-Y gastric bypass for morbidly obese patients: a risk reduction strategy Obes Surg 18 1575-82
[9]  
Larsson B(2008)Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects Obes Surg 18 1077-41
[10]  
Wedel H(2009)Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial Ann Surg 250 234-84
12345678910